Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non-small cell lung cancers

被引:2
|
作者
Zhang, Jia-Tao [1 ]
Dong, Song [2 ]
Ji, Li-Yan [3 ]
Zhou, Jia-Ying [2 ]
Chen, Zhi- Hong [2 ]
Su, Jian [2 ]
Zhu, Qing-Ge [3 ]
Wang, Meng-Min [2 ]
Ke, E-E [2 ]
Sun, Hao [2 ]
Li, Xue-Tao [2 ]
Yang, Jin-Ji [2 ]
Zhou, Qing [2 ]
Zhang, Xu-Chao [2 ]
Gao, Xuan [3 ]
Yang, Xue-Ning [2 ]
Xia, Xuefeng [3 ]
Yi, Xin [3 ]
Zhong, Wen-Zhao [1 ,2 ]
Wu, Yi-Long [1 ,2 ]
机构
[1] Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China
[2] Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangzhou 510080, Guangdong, Peoples R China
[3] Geneplus Beijing Inst, Beijing, Peoples R China
关键词
chromosomal instability; clonal structure; immune microenvironment; intratumoral heterogeneity; metastasis; CHROMOSOMAL INSTABILITY; EVOLUTION; CHECKPOINTS;
D O I
10.1111/1759-7714.14393
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Starting with low metastatic capability, T4N0M0 (diameter >= 7 cm) non-small cell lung cancers (NSCLCs) constitute a unique tumor subset, as with a large tumor size but no regional or distant metastases. We systematically investigated intratumoral heterogeneity, clonal structure, chromosomal instability (CIN), and immune microenvironment in T4N0M0 (>= 7 cm) NSCLCs. Methods Whole-exome sequencing, RNA sequencing, and multiplex immunohistochemistry (mIHC) staining were conducted to analyze 24 spatially segregated tumor samples from eight patients who were pathologically diagnosed with T4N0M0 (diameter >= 7 cm) NSCLCs. The adjacent normal tissues and peripheral blood served as controls. Results In total, 35.2% of mutations and 91.1% of somatic copy number alterations were classified as subclonal events, which exhibited widespread genetic intratumoral heterogeneity. In contrast, a low degree of CIN was observed. None of the patients had genome doubling. The burden of loss of heterozygosity, aneuploidy, and the genome instability index of these tumors were significantly lower than those in the TRACERx cohort. Expression profiles revealed significantly upregulated expression of cell division-related signals and the G2/M checkpoint pathway. In addition, a similar expression pattern of the immune microenvironment was observed in different regions of the tumor, which was confirmed by mIHC profiles. Conclusions Our study indicates the presence of intratumoral genetic heterogeneity and immune microenvironmental heterogeneity features in T4N0M0 NSCLCs, and the low degree of CIN may be related to the low metastatic capability.
引用
收藏
页码:1333 / 1341
页数:9
相关论文
共 50 条
  • [1] Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer
    Eriguchi, Takahisa
    Takeda, Atsuya
    Sanuki, Naoko
    Nishimura, Shuichi
    Takagawa, Yoshiaki
    Enomoto, Tatsuji
    Saeki, Noriyuki
    Yashiro, Kae
    Mizuno, Tomikazu
    Aoki, Yousuke
    Oku, Yohei
    Yokosuka, Tetsuya
    Shigematsu, Naoyuki
    JOURNAL OF RADIATION RESEARCH, 2016, 57 (03) : 265 - 272
  • [2] Segmentectomy for c-T1N0M0 non-small cell lung cancer
    Hiroaki Nomori
    Surgery Today, 2014, 44 : 812 - 819
  • [3] Segmentectomy for c-T1N0M0 non-small cell lung cancer
    Nomori, Hiroaki
    SURGERY TODAY, 2014, 44 (05) : 812 - 819
  • [4] Factors Associated with Nodal Upstaging in Clinical T1a-bN0M0 Non-Small Cell Lung Cancers
    Tsai, Tung-Ming
    Liu, Chao-Yu
    Lin, Mong-Wei
    Hsu, Hsao-Hsun
    Chen, Jin-Shing
    CANCERS, 2022, 14 (05)
  • [5] Cryoablation for T1N0M0 non-small cell lung cancer using liquid nitrogen
    Nomori, Hiroaki
    Yamazaki, Ikuo
    Shiraishi, Atsushi
    Adachi, Tetsuya
    Kanno, Masaya
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 133
  • [6] Oncologic Outcomes of Patients with Resected T3N0M0 Non-small Cell Lung Cancer
    Marques, E.
    Kennedy, K.
    Nishimura, K.
    Giroux, D.
    Cilento, V.
    Fang, W.
    Ugalde, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S866 - S867
  • [7] Oncologic Outcomes of Patients With Resected T3N0M0 Non-small Cell Lung Cancer
    Marques, Edouard
    Kennedy, Kevin F.
    Giroux, Dorothy J.
    Cilento, Vanessa B.
    Nishimura, Katherine K.
    Fang, Wentao
    Figueroa, Paula Ugalde
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (04) : 796 - 804
  • [8] Adjuvant chemotherapy for patients with T2N0M0 non-small cell lung cancer.
    Morgensztern, Daniel
    Waqar, Saiama Naheed
    Patel, Aalok
    Devarakonda, Siddhartha
    Waqar, Sadaf Huma
    Gao, Feng
    Robinson, Cliff Grant
    Bradley, Jeffrey D.
    Baggstrom, Maria Quintos
    Govindan, Ramaswamy
    Puri, Varun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Surgical approach in T4N0M0 (vertebral involvement) lung cancerAbord chirurgical dans les cancers pulmonaires TAN0M0 (avec implication vertébrale)
    Ufuk Aydinli
    Cengiz Gebitekin
    Sami Bayram
    Cagatay Ozturk
    Salim Ersozlu
    European Journal of Orthopaedic Surgery & Traumatology, 2004, 14 (3) : 142 - 146
  • [10] T1aN0M0 and T1bN0M0 Non-Small Cell Lung Cancer: A Retrospective Study of the Prognosis
    Zhang, Zhenfa
    Wang, Anlei
    Zhan, Zhongli
    Sun, Leina
    Chen, Kexin
    Wang, Changli
    THORACIC AND CARDIOVASCULAR SURGEON, 2014, 62 (02): : 109 - 116